Exhaled NO in diffuse alveolar haemorrhage [5]

Thorax

Volumn 60, Issue 7, 2005, Pages 614-615

  Rolla, G ^a,b   Heffler, E ^a   Guido, G ^a   Bergia, R ^a   Bucca, C ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUTICASONE; METHYLPREDNISOLONE; NITRIC OXIDE; PREDNISOLONE; SALMETEROL;

ADULT; ASTHMA; CASE REPORT; CHURG STRAUSS SYNDROME; DIFFUSE ALVEOLAR HEMORRHAGE; DISEASE MARKER; EXPIRED AIR; HUMAN; LETTER; LOBAR PNEUMONIA; LUNG HEMORRHAGE; MALE; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

BREATH TESTS; BRONCHOALVEOLAR LAVAGE FLUID; EXHALATION; HEMORRHAGE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; NITRIC OXIDE; PULMONARY ALVEOLI;

EID: 22044435983     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.040287     Document Type: Letter

References (5)

1. Bradley JD. The pulmonary hemorrhage syndromes. Clin Chest Med 1982;3:593-605.
2. Greening AP, Hughes JMB. Serial estimations of carbon monoxide diffusing capacity in intrapulmonary haemorrhage. Clin Sci 1981;60:507-12.
3. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children, 1999. Am J Respir Crit Care Med 1999;160:2104-17.
4. Worthy SA, Muller NL, Hansell DM, et al. Churg-Strauss syndrome: the spectrum of CT findings in 17 patients. Am J Roentgenol 1998;170:297-300.
5. Adrie C, Monchi M, Dinh-Xuan AT, et al. Exhaled and nasal nitric oxide as a marker of pneumonia in ventilated patients. Am J Respir Crit Care Med 2001;163:1143-9.